Search - tctmd.com

Displaying 101 - 120 of 164

Sort: Relevancy | Date

News Conference News ACC 2019

ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend

Shelley Wood

March 11, 2019

News Daily News

‘Watchful Waiting’ Tied to Poor Long-term Outcomes in Patients With Severe AR, Analysis Suggests

L.A. McKeown

January 17, 2019

News Daily News

Appropriate Use Criteria Tackle Imaging in Nonvalvular Structural Heart Disease

Caitlin E. Cox

January 07, 2019

News Conference News VIVA 2018

Now You See Them, Now You Don’t: Bioresorbable Devices Target Large-Bore Closures and PE Prevention

L.A. McKeown

November 09, 2018

News Daily News

Echo Parameters Identify At-Risk Asymptomatic Patients With Severe AS

Michael O'Riordan

October 03, 2018

Presentation

Outcomes of Patients with Asymptomatic Aortic Stenosis (AS) Followed Up in Heart Valve Clinics

October 03, 2018

Presentation TCT 2018

Case #8: A Case of Asymptomatic Leaflet Thrombosis: Management Strategies

Presenter: Philippe Genereux, Josep Rodés-Cabau, Suzanne V. Arnold, Wayne B. Batchelor, Pablo Lamelas, Tullio Palmerini, Shigeru Saito, Tobias Tichelbäcker

September 23, 2018

Presentation TCT 2018

Putting It All Together: A Proposed New Staging Classification for Patients with Aortic Stenosis

Presenter: Philippe Genereux

September 22, 2018

Presentation TCT 2018

Who Should be Treated? The Role of Biomarkers in Patient Selection and Procedure Optimization

Presenter: Eric Van Belle

September 22, 2018

Presentation TCT 2018

Who Should be Treated? The Role of Imaging Guidance in Patient Selection

Presenter: Philippe Pibarot

September 22, 2018

Presentation TCT 2018

Rationale for Treating SASS and Update of the EARLY-TAVR Trial

Presenter: Allan Schwartz

September 22, 2018

News Conference News TCT 2018

Novel LAA Closure Device Shows Promise in Early Experience

L.A. McKeown

September 22, 2018

News Conference News PCR London Valves 2018

No Symptoms? Some AS Patients Undergo Valve Replacement Despite Lack of Clinical Indication

Shelley Wood

September 12, 2018

News Conference News PCR London Valves 2018

Ten-Year Trends in the UK Show TAVR Rates Rising but SAVR Holding Steady

Shelley Wood

September 11, 2018

News Daily News

Global Longitudinal Strain May Help Predict Need for Early Intervention in Asymptomatic Severe AS

L.A. McKeown

August 20, 2018

Presentation The Structural Heart Disease Summit 2018

CLINICAL VIEWPOINT: Problems With the Current Practice of Watchful Waiting in Managing Asymptomatic Patients With Severe AS

Presenter: Howard C. Herrmann, Allan Schwartz

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Status Update of the EARLY TAVR Trial Asymptomatic Severe AS Patients

Presenter: Howard C. Herrmann, Allan Schwartz, Philippe Genereux

June 22, 2018

News Daily News

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

Michael O'Riordan

June 20, 2018

Presentation ECHO 2018

The Role of Echo in the Management of Asymptomatic VHD

Presenter: Philippe Pibarot

April 18, 2018

News Daily News

LV Diastolic Dysfunction Linked With Higher Mortality Post-TAVR

Yael L. Maxwell

March 01, 2018

Advertisement

ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend

‘Watchful Waiting’ Tied to Poor Long-term Outcomes in Patients With Severe AR, Analysis Suggests

Appropriate Use Criteria Tackle Imaging in Nonvalvular Structural Heart Disease

Now You See Them, Now You Don’t: Bioresorbable Devices Target Large-Bore Closures and PE Prevention

Echo Parameters Identify At-Risk Asymptomatic Patients With Severe AS

Outcomes of Patients with Asymptomatic Aortic Stenosis (AS) Followed Up in Heart Valve Clinics

Case #8: A Case of Asymptomatic Leaflet Thrombosis: Management Strategies

Putting It All Together: A Proposed New Staging Classification for Patients with Aortic Stenosis

Who Should be Treated? The Role of Biomarkers in Patient Selection and Procedure Optimization

Who Should be Treated? The Role of Imaging Guidance in Patient Selection

Rationale for Treating SASS and Update of the EARLY-TAVR Trial

Novel LAA Closure Device Shows Promise in Early Experience

No Symptoms? Some AS Patients Undergo Valve Replacement Despite Lack of Clinical Indication

Ten-Year Trends in the UK Show TAVR Rates Rising but SAVR Holding Steady

Global Longitudinal Strain May Help Predict Need for Early Intervention in Asymptomatic Severe AS

CLINICAL VIEWPOINT: Problems With the Current Practice of Watchful Waiting in Managing Asymptomatic Patients With Severe AS

Status Update of the EARLY TAVR Trial Asymptomatic Severe AS Patients

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

The Role of Echo in the Management of Asymptomatic VHD

LV Diastolic Dysfunction Linked With Higher Mortality Post-TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content